TG6002: a novel oncolytic and vectorized gene-prodrug therapy approach to treat glioblastoma


Johann Foloppe, et al.
International Oncolytic Virus Conference, April 2018
Download the poster here
Poster Presentation

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2021 Transgene - All rights reserved
Terms of use - Credits